Health

The FDA approved a new Alzheimer's drug, but experts warn of serious side effects and limited efficacy. The decision sparks heated debate.

UK becomes first country to approve cultivated meat for pet food, opening a new frontier for lab-grown protein.

First confirmed H5N1 infection in domestic cats in Texas raises zoonotic spillover concerns as CDC investigates transmission routes.

FDA clears oral antibiotic gepotidacin for uncomplicated UTIs in women, offering a novel option amid rising resistance.

The US reports its first human death from H5N1 bird flu, raising urgent questions about pandemic preparedness and viral mutations.

A new study finds microplastics in human testicles, linking them to declining sperm counts and fertility issues.

FDA halts trial of experimental Alzheimer's drug due to liver toxicity concerns.

A clinical trial for a CRISPR-based blindness treatment was halted after severe side effects emerged in multiple patients.

The CDC issued a health alert yesterday after detecting a novel H5N1 mutation in a Louisiana patient, raising pandemic concerns.

The FDA suzetrigine approval is a landmark moment in pain management, offering a non-addictive alternative to opioids.

New FDA investigation into semaglutide drugs like Ozempic finds possible suicide risk signal, raising questions about GLP-1 safety monitoring.

FDA approves new Alzheimer's drug donanemab, a monoclonal antibody that targets amyloid plaques. Eli Lilly stock jumps 4.2% on the news.